Volume 65, Issue 4, Pages (October 2016)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 46, Issue 3, Pages (March 2007)
Inflammasomes in liver diseases
Volume 58, Issue 2, (February 2013)
Volume 58, Issue 2, (February 2013)
Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials  Pippa Newell, Augusto Villanueva, Josep M. Llovet 
Pathological roles of purinergic signaling in the liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Thrombocytopenia associated with chronic liver disease
Florie Borel, Pavlina Konstantinova, Peter L.M. Jansen 
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Deregulating EMT and Senescence: Double Impact by a Single Twist
Epithelial-Mesenchymal Transitions
Chadrick E. Denlinger, MD, John S. Ikonomidis, MD, PhD, Carolyn E
Mesenchymal stromal cell therapy for liver diseases
Mechanisms of HBV-related hepatocarcinogenesis
The place of downstaging for hepatocellular carcinoma
Volume 66, Issue 2, Pages (February 2017)
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Jean-Charles Nault, Peter R. Galle, Jens U. Marquardt 
Targeting gut flora to prevent progression of hepatocellular carcinoma
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Why men are at higher risk for hepatocellular carcinoma?
Volume 45, Issue 4, Pages (October 2006)
Volume 69, Issue 2, Pages (August 2018)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 59, Issue 3, Pages (September 2013)
Deregulating EMT and Senescence: Double Impact by a Single Twist
EASL Clinical Practice Guidelines: Wilson’s disease
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
Volume 54, Issue 5, Pages (May 2011)
Fig. 4. miR-370 restoration suppressed EMT progression in HCC cells
Marcel Klingenberg, Akiko Matsuda, Sven Diederichs, Tushar Patel 
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
miR-122 – A key factor and therapeutic target in liver disease
Evolution of liver transplantation for hepatocellular carcinoma
Volume 68, Issue 5, Pages (May 2018)
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
The dynamic biliary epithelia: Molecules, pathways, and disease
Twist: a new link from hypoxia to fibrosis
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Statins: Old drugs as new therapy for liver diseases?
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
EpCAM in hepatocytes and their progenitors
Foxa1 and Foxa2 regulate bile duct development in mice
Genetics of hepatocellular carcinoma: The next generation
Nathalie Ganne-Carrié, Pierre Nahon  Journal of Hepatology 
Shih-Yen Weng, Detlef Schuppan  Journal of Hepatology 
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 65, Issue 4, Pages 798-808 (October 2016) Role of epithelial to mesenchymal transition in hepatocellular carcinoma  Gianluigi Giannelli, Petra Koudelkova, Francesco Dituri, Wolfgang Mikulits  Journal of Hepatology  Volume 65, Issue 4, Pages 798-808 (October 2016) DOI: 10.1016/j.jhep.2016.05.007 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The cellular heterogeneity of HCC by EMT-MET. The differentiation repertoire of malignant hepatocytes or progenitor cells contributes to the mosaic phenotype of HCC cells via partial or complete EMT-MET, as well as changes in the cell plasticity of HSCs in chronic liver disease. Left panel: Human HCC samples stained with anti-E-cadherin (E-cadherin) antibody. E-cadherin localizes at adhering cell-cell junctions in differentiated HCC while poorly differentiated HCC show either redistribution of E-cadherin to the cytoplasm or loss of its expression. Right panel: Scheme depicting the differentiation potential of hepatocytes and HSCs. Epitheloid HSCs provide an even higher complexity of HCC heterogeneity through a possible “liver cell panplasticity” in the underlying fibrosis [28]. Journal of Hepatology 2016 65, 798-808DOI: (10.1016/j.jhep.2016.05.007) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Key regulators impinging on EMT-TFs in hepatocellular EMT and HCC progression. Multiple regulatory components either activate or repress Snail, Twist or ZEB transcription factors which are involved in the downregulation of E-cadherin, resulting in EMT. Journal of Hepatology 2016 65, 798-808DOI: (10.1016/j.jhep.2016.05.007) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Triggers of EMT in HCC. Schematic representation of molecular pathways triggering EMT in HCC development and progression [105,109–115]. Journal of Hepatology 2016 65, 798-808DOI: (10.1016/j.jhep.2016.05.007) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions